Rikke Holm Hansen

Medicin og biovidenskab

1. Dimethyl Fumarate 100%
2. Multiple Sclerosis 88%
3. Helper-Inducer T-Lymphocytes 67%
4. Relapsing-Remitting Multiple Sclerosis 62%
5. Chronic Progressive Multiple Sclerosis 49%
6. T-Lymphocytes 41%
7. B-Lymphocytes 30%
8. Cerebrospinal Fluid 27%
9. ofatumumab 25%
10. Mucosal-Associated Invariant T Cells 25%
11. Cladribine 22%
12. Huntington Disease 17%
13. Therapeutics 16%
14. B-Lymphocyte Subsets 15%
15. Myelin Basic Protein 14%
16. Intermediate Filaments 13%
17. Randomized Controlled Trials 13%
18. Cell Movement 12%
19. Flow Cytometry 12%
20. Fumarates 11%
21. Biomarkers 11%
22. T-Lymphocyte Subsets 11%
23. Inflammation 10%
24. Placebos 10%
25. Cytokines 10%
26. Central Nervous System 9%
27. Interleukin-7 8%
28. Light 8%
29. Interleukin-17 8%
30. Regulatory T-Lymphocytes 7%
31. Genes 6%
32. Lymphotoxin-alpha 6%
33. Datasets 5%
34. Alemtuzumab 5%